Patents Assigned to Pulmonx
  • Publication number: 20200405318
    Abstract: The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment.
    Type: Application
    Filed: July 15, 2020
    Publication date: December 31, 2020
    Applicant: Pulmonx Corporation
    Inventors: Nikolai Aljuri, Rodney C. Perkins, Niyazi Beyhan
  • Patent number: 10869647
    Abstract: Devices, methods, and systems are provided for analyzing lung imaging data. A server computing device receives imaging data of a lung over a network from a client computing device and analyzes the imaging data to identify lung, airways, and blood vessels, segment the lung into lobes, subtract airways, calculate volumes, calculate emphysema scores, identify fissure locations, calculate fissure completeness scores. A reconstruction of the fissures indicating locations where the fissures are incomplete and a report comprising fissure scores, volumes, and emphysema scores are created.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: December 22, 2020
    Assignee: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Publication number: 20200352695
    Abstract: Devices, systems, and methods for measuring the diameter of an airway in a human or animal subject are disclosed. The device comprises a flexible catheter body having a proximal end and a distal end. Flexible sizing elements are disposed along and extend approximately orthogonally from the catheter body. The sizing elements have different heights from one another and are configured to fit through the working channel of a bronchoscope. Devices, systems, and methods for redirecting airflow through a lung airway are also disclosed. The method comprises introducing into the airway a catheter comprising a distal end, a proximal end and an elongated portion therebetween, wherein the distal end comprises an airway closing mechanism, and wherein the proximal end comprises an actuator to actuate the airway closing mechanism; and actuating the airway closing mechanism to at least partially close the airway.
    Type: Application
    Filed: July 27, 2020
    Publication date: November 12, 2020
    Applicant: PulmonX Corporation
    Inventors: Ryan Olivera, Srikanth Radhakrishnan
  • Publication number: 20200352696
    Abstract: Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region. An exemplary flow control device is configured to block fluid flow in the inspiratory direction and the expiratory direction at normal breathing pressures and allow fluid flow in the expiratory direction at higher than normal breathing pressures.
    Type: Application
    Filed: July 28, 2020
    Publication date: November 12, 2020
    Applicant: PulmonX Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Publication number: 20200329996
    Abstract: A method for determining lung function in a patient is disclosed, in which a multi-lumen catheter with an expandable occluding element at its end is used to isolate a targeted lung compartment, and respiratory characteristics at the targeted lung compartment are measured over multiple respiratory cycles. The relation between various characteristics of the respiratory cycle is used to determine compliance of lung tissue within the targeted lung compartment.
    Type: Application
    Filed: April 23, 2020
    Publication date: October 22, 2020
    Applicant: Pulmonx Corporation
    Inventors: Srikanth Radhakrishnan, Surag Mantri, Ryan Olivera
  • Patent number: 10758239
    Abstract: The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment.
    Type: Grant
    Filed: November 22, 2016
    Date of Patent: September 1, 2020
    Assignee: Pulmonx Corporation
    Inventors: Nikolai Aljuri, Rodney C. Perkins, Niyazi Beyhan
  • Patent number: 10758333
    Abstract: Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region. An exemplary flow control device is configured to block fluid flow in the inspiratory direction and the expiratory direction at normal breathing pressures and allow fluid flow in the expiratory direction at coughing pressures.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: September 1, 2020
    Assignee: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Patent number: 10743978
    Abstract: Devices, systems, and methods for measuring the diameter of an airway in a human or animal subject are disclosed. The device comprises a flexible catheter body having a proximal end and a distal end. Flexible sizing elements are disposed along and extend approximately orthogonally from the catheter body. The sizing elements have different heights from one another and are configured to fit through the working channel of a bronchoscope. Devices, systems, and methods for redirecting airflow through a lung airway are also disclosed. The method comprises introducing into the airway a catheter comprising a distal end, a proximal end and an elongated portion therebetween, wherein the distal end comprises an airway closing mechanism, and wherein the proximal end comprises an actuator to actuate the airway closing mechanism; and actuating the airway closing mechanism to at least partially close the airway.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: August 18, 2020
    Assignee: Pulmonx Corporation
    Inventors: Ryan Olivera, Srikanth Radhakrishnan
  • Patent number: 10631758
    Abstract: A method for determining lung function in a patient is disclosed, in which a multi-lumen catheter with an expandable occluding element at its end is used to isolate a targeted lung compartment, and respiratory characteristics at the targeted lung compartment are measured over multiple respiratory cycles. The relation between various characteristics of the respiratory cycle is used to determine compliance of lung tissue within the targeted lung compartment.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: April 28, 2020
    Assignee: Pulmonx Corporation
    Inventors: Srikanth Radhakrishnan, Surag Mantri, Ryan Olivera
  • Publication number: 20200107776
    Abstract: Lung conditions are diagnosed and optionally treated using a functional assessment catheter or a functional lung assessment and treatment catheter. A flow restrictive component is initially placed in a bronchus or lung passageway upstream from a diseased lung region. The isolated lung region is then functionally assessed through the catheter, while the flow restrictive component remains in place. If the patient is a good candidate for treatment by occlusive or restrictive treatment techniques, the flow resistive component may be left in place. If the patient is not suitable for such treatment, the flow resistive component may be removed.
    Type: Application
    Filed: December 6, 2019
    Publication date: April 9, 2020
    Applicant: Pulmonx Corporation
    Inventors: Ajit Nair, Son Gia, Roger Farhnoltz, Nikolai Aljuri
  • Publication number: 20200038086
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Application
    Filed: October 2, 2019
    Publication date: February 6, 2020
    Applicant: Pulmonx Corporation
    Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair
  • Publication number: 20200038612
    Abstract: The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment. The invention further discloses a catheter with a transparent occlusion element at its tip that enables examination of the lung passageway through a viewing scope.
    Type: Application
    Filed: May 31, 2019
    Publication date: February 6, 2020
    Applicant: Pulmonx Corporation
    Inventors: Nikolai Aljuri, Rodney C. Perkins, Ryan Olivera, Hoang Nguyen, Srikanth Radhakrishnan, Niyazi Beyhan
  • Publication number: 20200037958
    Abstract: Devices systems and methods are disclosed for removing secretions from the lumen of a functional assessment catheter for the lungs. The system comprises a flushing unit configured to deliver a clearing fluid to the lumen of the pulmonary catheter to remove debris, secretions, or moisture from the lumen or sensors.
    Type: Application
    Filed: October 2, 2019
    Publication date: February 6, 2020
    Applicant: Pulmonx Corporation
    Inventor: Lutz Freitag
  • Publication number: 20200030075
    Abstract: Devices, methods, and systems are provided for loading an implantable device into a container. One aspect of the loading system contains a loader element with a loading tunnel that is configured to gradually contract an implantable device into a compressed state of reduced size relative to an expanded state as the implantable device travels through the loading tunnel.
    Type: Application
    Filed: June 10, 2019
    Publication date: January 30, 2020
    Applicant: Pulmonx Corporation
    Inventors: Ryan Olivera, Hoang Nguyen
  • Publication number: 20200022706
    Abstract: Devices, methods, and systems are provided for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment. A video-assisted thoracoscopic device is inserted into a thoracic cavity of a patient and positioned at a fissure between a target lung compartment and an adjacent lung compartment. A collateral flow channel between the target lung compartment and the adjacent lung compartment is then identified using the video-assisted thoracoscopic device and an agent is injected into the collateral flow channel, thereby reducing the collateral flow channel.
    Type: Application
    Filed: August 6, 2019
    Publication date: January 23, 2020
    Applicant: Pulmonx Corporation
    Inventors: Sri Radhakrishnan, Ryan Olivera
  • Patent number: 10517529
    Abstract: Lung conditions are diagnosed and optionally treated using a functional assessment catheter or a functional lung assessment and treatment catheter. A flow restrictive component is initially placed in a bronchus or lung passageway upstream from a diseased lung region. The isolated lung region is then functionally assessed through the catheter, while the flow restrictive component remains in place. If the patient is a good candidate for treatment by occlusive or restrictive treatment techniques, the flow resistive component may be left in place. If the patient is not suitable for such treatment, the flow resistive component may be removed.
    Type: Grant
    Filed: August 30, 2016
    Date of Patent: December 31, 2019
    Assignee: Pulmonx Corporation
    Inventors: Ajit Nair, Son Gia, Roger Farhnoltz, Nikolai Aljuri
  • Publication number: 20190388034
    Abstract: The present invention provides systems, methods, devices and kits for assessing the level of pulmonary disease in individual lung compartments. A lung compartment comprises a subportion of a lung, such as a lobe, a segment or a subsegment, for example. By measuring individual lung compartments, the level of disease of the pulmonary system may be more precisely defined by determining values of disease parameters reflective of individual subportions or compartments of a lung. Likewise, compartments may be separately imaged to provide further measurement information. Once individual compartments are characterized, they may be compared and ranked based on a number of variables reflecting, for example, level of disease or need for treatment. Such comparison may be aided by simultaneous display of such variables or images on a visual display. Further, the same tests may be performed on the lung as a whole or on both lungs and to determine the affect of the diseased lung compartments on the overall lung performance.
    Type: Application
    Filed: September 5, 2019
    Publication date: December 26, 2019
    Applicant: Pulmonx Corporation
    Inventors: Robert Kotmel, Peter Soltesz, Anthony Wondka, Rodney Perkins
  • Publication number: 20190380619
    Abstract: A method of diagnosing an air leak in a lung compartment of a patient may include: advancing a diagnostic catheter into an airway leading to the lung compartment; inflating an occluding member on the catheter to form a seal with a wall of the airway and thus isolate the lung compartment; measuring air pressure within the lung compartment during multiple breaths, using the diagnostic catheter; displaying the measured air pressure as an air pressure value on a console coupled with the diagnostic catheter; and determining whether an air leak is present in the lung compartment based on the displayed air pressure value during the multiple breaths.
    Type: Application
    Filed: June 5, 2019
    Publication date: December 19, 2019
    Applicant: Pulmonx Corporation
    Inventor: Surag MANTRI
  • Patent number: 10478125
    Abstract: Devices systems and methods are disclosed for removing secretions from the lumen of a functional assessment catheter for the lungs. The system comprises a flushing unit configured to deliver a clearing fluid to the lumen of the pulmonary catheter to remove debris, secretions, or moisture from the lumen or sensors.
    Type: Grant
    Filed: March 3, 2014
    Date of Patent: November 19, 2019
    Assignee: Pulmonx Corporation
    Inventor: Lutz Freitag
  • Patent number: 10470811
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Grant
    Filed: October 24, 2016
    Date of Patent: November 12, 2019
    Assignee: Pulmonx Corporation
    Inventors: Peter P. Soltesz, Nikolai Aljuri, Ajit Nair